Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID)

BACKGROUND: Symptom expression in SARS-CoV-2 infection (COVID-19) may affect patients already symptomatic with cancer. Patient-reported outcomes (PROs) can describe symptom burden during the acute and postacute stages of COVID-19 and support risk stratification for levels of care. At the start of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Loretta A., Whisenant, Meagan S., Mendoza, Tito R., Peek, Angela E., Malveaux, Donna, Griffin, Donna K., Ponce, Darcy A., Granwehr, Bruno Palma, Sheshadri, Ajay, Hutcheson, Katherine A., Ali, Sara M., Peterson, Susan K., Heymach, John V., Cleeland, Charles S., Subbiah, Ishwaria M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215036/
https://www.ncbi.nlm.nih.gov/pubmed/37237077
http://dx.doi.org/10.1186/s41687-023-00591-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215036/
https://www.ncbi.nlm.nih.gov/pubmed/37237077
http://dx.doi.org/10.1186/s41687-023-00591-x

Ejemplares similares